Unknown

Dataset Information

0

Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data.

ABSTRACT:

SUBMITTER: Thomas L 

PROVIDER: S-EPMC8404633 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies.
| S-EPMC7670900 | biostudies-literature
Unknown Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis.
| S-EPMC8299294 | biostudies-literature
Unknown Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse.
| S-EPMC7524612 | biostudies-literature
Unknown Advances in the computational landscape for repurposed drugs against COVID-19.
| S-EPMC8323501 | biostudies-literature
Unknown How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs.
| S-EPMC7180704 | biostudies-literature
Unknown PreDTIs: prediction of drug-target interactions based on multiple feature information using gradient boosting framework with data balancing and feature selection techniques.
| S-EPMC7989622 | biostudies-literature
Unknown Prediction of repurposed drugs for treating lung injury in COVID-19.
| S-EPMC7280878 | biostudies-literature
Unknown Prediction of repurposed drugs for treating lung injury in COVID-19.
| S-EPMC7468567 | biostudies-literature
Unknown A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information.
| S-EPMC5603535 | biostudies-literature
Unknown Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning.
| S-EPMC8141697 | biostudies-literature